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Introduction: Telemonitoring offers a potential solution to the challenge of providing care for the 
increasing number of people living with long-term conditions such as chronic obstructive 
pulmonary disease (COPD). Five systematic reviews have concluded that the evidence for 
telemonitoring in COPD is inconclusive. Telemonitoring interventions generally include enhanced 
clinical care in order to provide monitoring services so that it is unclear if telemonitoring alone 
improves clinical outcomes and reduces hospital admissions 
 
Aim To determine if telemetrically supported self-monitoring of COPD postpones hospital 
admissions when both intervention and control groups receive optimised care. 
 
Methods: This was a one-year, researcher-blind randomised controlled trial in UK primary care. 
Patients with a COPD admission in the previous year were randomised centrally to telemonitoring 
or traditional modes of monitoring: both groups received the same clinical care. The primary 
outcome, assessed by a researcher blinded to allocation, was time to first hospital admission 
caused by a COPD exacerbation over the trial year. Other outcomes included number of  
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admissions, bed days, deaths and health-related quality of life (St George’s Respiratory 
Questionnaire (SGRQ)). The specialist community services recorded details of all contacts with the 
186 patients under their services. 
 
Results: We randomised 256 patients (128 to telemonitoring): baseline characteristics were 
similar in both groups. Using an intention-to-treat analysis, there was no significant difference in 
the hazard ratio (HR) for admission in the control group compared with the telemonitoring group: 
adjusted HR 1.02 (95% CI 0.70 to 1.49). 61 patients in each group had an admission. There was 
no significant difference in the mean number of admissions per person (telemonitoring: 1.2 (SD 
1.9), control: 1.1 (SD 1.6) p=0.54), or in their duration (telemonitoring: 9.4 days (SD 19.1) vs 
control 8.8 days (SD 15.9) p=0.66). There were 16/128 deaths in the telemonitoring group and 
21/128 deaths in the control group: this difference was not statistically significant (OR 0.73 95%CI 
0.36 to 1.47). Telemonitoring did not affect quality of life (mean St Georges Respiratory 
Questionnaire at 1 year: telemonitoring 68.2 (SD 16.3) vs control 67.3 (SD 17.3), mean difference 
1.55 (95% CI -1.44 to 4.53). 
 
There were 2,431 alerts resulting in telephone contacts with the 93 telemonitoring patients under 
the care of the community teams, 112 of which resulted in a home visit. In addition, the 
telemonitoring patients received 521 telephone calls and 819 home visits which were not 
associated with alerts. By comparison, the patients in the control group only received 352 
telephone calls and 682 home visits. 
 
Conclusions: When both groups received optimised care, telemonitoring did not appear to reduce 
the time to a hospital admission, duration of hospital admissions or increase quality of life. 
Telemonitoring triggered a large number of alerts which resulted in a substantial increase in the 
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